The French National Agency for Medicines and Health Products Safety (ANSM) has conditionally authorized AMX0035, a new medication developed by the American laboratory Amylyx Pharmaceuticals
Systemic, long-term changes to the UK’s health system are required to tackle ‘unacceptable’ inequalities in diabetes care, according to a new report from the Diabetes
A new digital resource and patient education tool to help people with diabetes keep their feet healthy has been launched to mark World Diabetes Day.
Insulet has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Omnipod 5 App for iPhone, making Insulet the first company to
A study of almost 100,000 eyes has found that semaglutide, a GLP-1 agonist recently approved for weight loss, does not worsen the progression of diabetic
The US Food and Drug Administration (FDA) has approved Eli Lilly’s Zepbound – a powerful new medicine for weight loss for adults with obesity or
Replacing meat and dairy with whole grains, beans, nuts and olive oil may significantly reduce cardiovascular disease and type 2 diabetes, according to a recet
Well, what a year 2023 was! It has been a privilege to report on the changes in recommendations that have come from NICE about access
Research by Dexcom has found that 79% of people struggle to keep their glucose levels in range, and that almost half (45%) don’t understand what
New research suggests that the diagnosis threshold for Type 2 diabetes should be lowered in women aged under 50 years, since natural blood loss through
